Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab.
Ann Oncol. 2008 Sep;19(9):1629-33. doi: 10.1093/annonc/mdn172. Epub 2008 Jun 2.
Ann Oncol. 2008.
PMID: 18522934